Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;14(11):1509-23.
doi: 10.1586/14760584.2015.1081067. Epub 2015 Aug 27.

Effect of vaccine administration modality on immunogenicity and efficacy

Lu Zhang  1   2 , Wei Wang  3 , Shixia Wang  4
Affiliations
Review

Effect of vaccine administration modality on immunogenicity and efficacy

Lu Zhang et al. Expert Rev Vaccines. 2015.

Abstract

The many factors impacting the efficacy of a vaccine can be broadly divided into three categories: features of the vaccine itself, including immunogen design, vaccine type, formulation, adjuvant and dosing; individual variations among vaccine recipients and vaccine administration-related parameters. While much literature exists related to vaccines, and recently systems biology has started to dissect the impact of individual subject variation on vaccine efficacy, few studies have focused on the role of vaccine administration-related parameters on vaccine efficacy. Parenteral and mucosal vaccinations are traditional approaches for licensed vaccines; novel vaccine delivery approaches, including needless injection and adjuvant formulations, are being developed to further improve vaccine safety and efficacy. This review provides a brief summary of vaccine administration-related factors, including vaccination approach, delivery route and method of administration, to gain a better understanding of their potential impact on the safety and immunogenicity of candidate vaccines.

Keywords: administration; efficacy; immunogenicity; vaccination; vaccine; vaccine delivery.

PubMed Disclaimer

References

    1. Baxby D. Edward Jenner's Inquiry; a bicentenary analysis. Vaccine. 1999;17(4):301–7. - PubMed
    1. Public health then and now :celebrating 50 years of MMWR at CDC. U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, GA: 2011.
    1. Blundell TL, Sibanda BL, Sternberg MJ, Thornton JM. Knowledge-based prediction of protein structures and the design of novel molecules. Nature. 1987;326(6111):347–52. - PubMed
    1. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002;415(6872):694–701. - PubMed
    1. Scanlan CN, Offer J, Zitzmann N, Dwek RA. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature. 2007;446(7139):1038–45. - PubMed

Publication types